default image

Kindergesichtschirurgie

Information and services of the department

  • Number of inpatient cases: 130

Services search (in the department)


Illness Number of cases
Other localized connective tissue disorders - Localized scleroderma morphea (L94.0) 20
Cleft palate with cleft lip - Cleft hard and soft palate with unilateral cleft lip (Q37.5) 13
Cleft palate with cleft lip - Cleft hard palate with unilateral cleft lip (Q37.1) 10
Melanocytic naevi (D22.3) 9
Melanocytic naevi - Melanocytic nevi of scalp and neck (D22.4) 7
Cleft palate with cleft lip - Cleft hard and soft palate with bilateral cleft lip (Q37.4) 6
Voice disturbances (R49.2) 6
Cleft lip - Cleft lip unilateral (Q36.9) 5
Atrophic disorders of skin - Scar conditions and fibrosis of skin (L90.5) 4
Other congenital malformations of peripheral vascular system - Other specified congenital malformations of peripheral vascular system (Q27.8) 4
Treatment Number
Tattooing or injection of foreign material into the skin and subcutaneous tissues (5-890.14) 31
Operation to tighten the skin or subcutaneous tissues and remove fatty tissue, apart from the face (5-911.1e) 31
Surgical removal of diseased tissue from the skin or subcutaneous tissues (5-894.14) 27
Surgical incision into the eardrum (tympanic membrane) (5-200.5) 15
Operation using aids for optical magnification, e.g. magnifying spectacles, operating microscope (5-984) 15
Corrective surgery on the hard palate - palatoplasty (5-275.9) 12
Corrective surgery on a (congenital) cleft lip or cleft upper lip and jaw (5-276.a) 12
Corrective surgery on a (congenital) cleft lip or cleft upper lip and jaw (5-276.c) 10
Skin grafting from the area around the wound (5-903.54) 8
Tattooing or injection of foreign material into the skin and subcutaneous tissues (5-890.10) 6

Hospital information and services for all specialist departments

External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
  • Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
    No participation
Number Group
74 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
41 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
41 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”
Job Explanation
Project-related cooperation with colleges and universities EFIB Uni Heidelb., Max-Planck-Institut und Genetik der Ch.Berlin: Genetische Abklär. Fehlbildungen; Institut für Humangen.,Prof. Dr. M. Zenker (Uni Magdeburg): Thema Genetik von vaskulären Malformationen, Prof. Bachmann: Prof. Stephen Scott, King’s College London (“Fostering Changes”)
Lectureships / teaching posts at universities of applied sciences Prof. an der Universität Hamburg, Fachbereich Medizin; PD an der Universität Heidelberg, Fachbereich Medizin; Prof. an der Medical School Hamburg; Dozent Küstenländer Weiterbildung, Ausbildung von PJ- Studenten
Lectureships / teaching posts at colleges and universities Prof. Höger, Uni Hamburg, Prof. Bachmann: apl. Professor an der Philipps-Universität Marburg
Student training (clinical traineeship / internship year) PJ Student*innen der Universitäten Hamburg und UKSH/ Lübeck
Doctoral supervision Projekt: HPV-Infektionen bei LSA, Prof. Bachmann: Betreuung von Doktoranden an der Philipps-Universität Marburg
Editors of scientific journals/textbooks Zeitschrift "Pediatric Dermatology": Associate Editor Buch "Kinderdermatologie": Autor, 4. Aufl. 2021
Participation in multi-centre phase III/IV studies EPIK-2-Studie: Alpelisib bei PROS-Syndrom TIMBER/ASCEND-Studie: Topisches Retinoid bei Ichthyosen BRAVE-AA-Peds-Studie: Baricitinib bei Alopecia areata
No. Training in other healing professions Comment
HB03 Physical therapist / physiotherapist (m/f)
HB05 Medical technical radiology assistant (MTRA) (m/f)
HB16 Dietician (m/f)
HB02 Health and paediatric nurse (m/f)
HB06 Occupational therapist (m/f)

XX XX

Beschwerdemanagement

Phone: 4940 -181883-4422
Mail: moc.soipelksa@kebsdnaw.ofni

Sabine Neumann

Beschwerdebeauftragte, Sekretariat der Geschäftsführung

Phone: 040 -67377-243
Mail: ed.tfitsmlehliw-hkk@nnamuen.s

Heike Brost

Stv. Pflegedienstleitung, QM- Steuerungsgruppe

Phone: 040 -67377-298
Mail: ed.tfitsmlehliw-hkk@tsorb.h

Prof. Dr. Peter Höger

Chefarzt Pädiatrie, Ärztlicher Direktor

Phone: 040 -67377-202
Mail: ed.tfitsmlehliw-hkk@eirtaideap